Description

4-{(Z)-[9-Oxo-7-(Thiophen-2-Yl)-5,7-Dihydro-6H-Benzo[H][1,3]Thiazolo[2,3-B]Quinazolin-10(9H)-Ylidene]Methyl}Benzoic Acid is a sophisticated heterocyclic organic compound featuring a benzoic acid moiety fused with a complex thiazoloquinazolinone system. This compound is valued as a key advanced intermediate in the synthesis of novel pharmacologically active molecules, particularly in medicinal chemistry research. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers for developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the research and development of new drug candidates, especially those targeting specific enzyme pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to optimize the biological activity and pharmacokinetic properties of lead compounds.
• Organic Synthesis Reference Standard: Employed as a high-purity standard for analytical method development and validation in QC laboratories.
• Biochemical Probe Development: Utilized in the design and synthesis of molecular probes for studying biological processes and target identification.
• Academic Research: A valuable compound for universities and research institutes exploring novel heterocyclic chemistry and its applications.
• Fine Chemical Production: Acts as a precursor for the scaled-up synthesis of specialized, high-value chemical entities.

Basic Information

Product Name	4-{(Z)-[9-Oxo-7-(Thiophen-2-Yl)-5,7-Dihydro-6H-Benzo[H][1,3]Thiazolo[2,3-B]Quinazolin-10(9H)-Ylidene]Methyl}Benzoic Acid
CAS No.	445405-12-9
Molecular Formula	C27H16N2O3S2
Molecular Weight	480.56 g/mol
Synonyms	4-[(Z)-[9-Oxo-7-(thiophen-2-yl)-5,7-dihydro-6H-benzo[h][1,3]thiazolo[2,3-b]quinazolin-10(9H)-ylidene]methyl]benzoic acid; 4-{(Z)-[9-Oxo-7-(2-Thienyl)-5,7-dihydro-6H-benzo[h][1,3]thiazolo[2,3-b]quinazolin-10(9H)-ylidene]methyl}benzoic Acid; Benzoic acid, 4-[(Z)-[9-oxo-7-(2-thienyl)-5,7-dihydro-6H-benzo[h][1,3]thiazolo[2,3-b]quinazolin-10(9H)-ylidene]methyl]-; CAS 445405-12-9
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Every batch undergoes comprehensive analytical characterization using techniques such as HPLC, NMR, and mass spectrometry to confirm identity and purity. A detailed Certificate of Analysis (COA) is provided with each shipment, ensuring full traceability and compliance with your research specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The container should be kept in a well-ventilated area. Due to its complex structure, prolonged exposure to elevated temperatures or humidity should be avoided.

Specification

Item	Specification
Appearance	Yellow to orange solid powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 95.0% (Area %)
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.